Categories Multiple Myeloma

Xpovio Open to Advanced Myeloma Patients Outside US via Access Program

Xpovio Open to Advanced Myeloma Patients Outside US via Access Program People with advanced multiple myeloma and diffuse large B-cell lymphoma (DLBCL) will soon be able to access Xpovio (selinexor) outside the U.S. through a managed access program. This program, also known as a named patient program, allows patients and doctors in countries where a medicine is […]

Read More
Categories Cancer

Model Provides Template for High-Income & Emerging Economies to Plan Cancer Surgery Provision

Model Provides Template for High-Income & Emerging Economies to Plan Cancer Surgery Provision A guideline-based model described in The Lancet Oncology may provide a new template for high-income and emerging economies to rationally plan and evaluate their cancer surgery provision. The model replicates examples of benchmarking radiotherapy and chemotherapy demand for cancer surgery across all […]

Read More
Categories Cancer

University of Kansas Health System adds new radiation treatment for breast cancer patients

University of Kansas Health System adds new radiation treatment for breast cancer patients KANSAS CITY, Mo. — A local hospital is giving breast cancer patients a sign of hope with a new form of radiation treatment. Betty Dickinson, who lives in Plattsburg, Missouri is diligent about her mammograms. “I go with three or four other […]

Read More
Categories Cancer

CEO, Breast Cancer Survivor Discusses New Gel to Improve Sexual Quality of Life in Patients with …

CEO, Breast Cancer Survivor Discusses New Gel to Improve Sexual Quality of Life in Patients with … In 2018, Evofem Biosciences founder and CEO Saundra Pelletier was developing Phexxi, a non-hormonal contraceptive gel for women, when she was blindsided by a diagnosis of aggressive, stage 3 breast cancer. After treatments that included chemotherapy, a double […]

Read More
Categories Cancer

Study Results Appear to Support Larotrectinib Use in NTRK+ Lung Cancer

Study Results Appear to Support Larotrectinib Use in NTRK+ Lung Cancer Frequent and durable antitumor responses as well as extended survival were noted with the use of larotrectinib (Vitrakvi) in patients with NTRK gene fusion–positive advanced lung cancer, and these benefits extended to patients with central nervous system (CNS) metastases.1 Results were collected from 14 […]

Read More
Categories Multiple Myeloma

Fate Therapeutics (FATE) to Release Quarterly Earnings on Wednesday

Fate Therapeutics (FATE) to Release Quarterly Earnings on Wednesday Fate Therapeutics (NASDAQ:FATE) is set to issue its quarterly earnings data after the market closes on Wednesday, February 24th. Analysts expect the company to announce earnings of ($0.38) per share for the quarter. Shares of FATE stock opened at $110.18 on Friday. The stock has a […]

Read More